Sanofi/Orano Look To Next Steps After Phase II Radiotherapy Success

Radiotherapy hand
Sanofi and Orano Med announced positive Phase II results for AlphaMedix in GEP-NETs.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Advanced Therapies

More from Scrip